Selexis CHO Cells in Suspension-1

Presentations

Selexis enables biopharmaceutical companies to produce virtually any recombinant therapeutic protein, because we have the ability to understand and modify our cells to address productivity and expression challenges.

Whole Genome Sequencing for Cell Authentication and Determination of Product Quality

OCTOBER 3, 2017

Using whole genome sequencing, Selexis can generate repors to:

IDENTIFY AND PINPOINT INTEGRATION SITES of the transgene across the entire host genome and easily determine copy number of the gene coding sequence

DETECT FOR MUTATIONS(absences of insertions or deletions in the gene) and the integrity of the transgene

DETERMINE WHETHER YOUR CELL BANK IS MADE FROM A SINGLE CLONE OR NOT

View PDF